Galderma, the discreet Swiss botox empire
Galderma's market capitalization has doubled since its 2024 IPO, driven by the popularity of botulinum toxin injections.
Galderma's market capitalization has doubled since its 2024 IPO, driven by the popularity of botulinum toxin injections.